DSM-Firmenich AG (DSFIR) AI Stock Analysis

• Market Cap: €14.55B
• Dividend Yield: 3.61%
• Average Volume (3M): 727.24K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.57
• Revenue Growth: 4.46%
• EPS Growth: N/A
• Country: NL
• Employees: 26,301
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Household & Personal Products
• EPS (TTM): 0.65
• Shares Outstanding: 253,626,950
• 10 Day Avg. Volume: 620,056
• 30 Day Avg. Volume: 727,238
• PEG Ratio: 0.03
• Price to Book (P/B): 0.98
• Price to Sales (P/S): 1.97
• P/FCF Ratio: 28.57
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €72.16
• Price Target Upside: 18.80% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 8
• EPS Forecast (FY): 3.46
• Revenue Forecast (FY): €9.50B

• Rating: 52 Neutral
• Price Target: €63.00 ▲(3.72% Upside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is held back primarily by unstable financial performance (notably the 2025 revenue drop and net loss) and bearish technicals (below key moving averages with weak momentum). A relatively sound balance sheet and positive cash flow, along with an above-average dividend yield, provide partial support but do not offset the elevated near-term performance risk.

Positive Factors

Diversified B2B portfolio

DSM‑Firmenich's cross‑sector B2B product mix—fragrances, flavors, and functional ingredients—creates recurring demand from global consumer goods manufacturers. Diversification across end markets reduces revenue concentration risk and helps stabilize volumes versus single-segment players over the medium term.

Negative Factors

Volatile revenue trend

A pronounced revenue decline and erratic top‑line swings undermine predictability of cash flows and planning. Persistent volatility hampers capacity utilization, weakens pricing leverage, and raises the risk that investment and cost structures will be mismatched to demand for multiple quarters.

DSM-Firmenich AG Business Overview & Revenue Model

Company Description

DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery &...

Read more

DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery &...

How the Company Makes Money

DSM-Firmenich AG generates revenue through multiple key streams, primarily focusing on the sales of its wide range of flavor, fragrance, and nutritional products. The company leverages its extensive research and development capabilities to create ...

Read more

DSM-Firmenich AG generates revenue through multiple key streams, primarily focusing on the sales of its wide range of flavor, fragrance, and nutritional products. The company leverages its extensive research and development capabilities to create ...

DSM-Firmenich AG Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	9.03B	12.80B	10.63B	8.39B	11.44B
Gross Profit	3.53B	4.25B	2.61B	2.78B	4.19B
EBITDA	3.85B	561.00M	822.00M	1.31B	1.45B
Net Income	-1.08B	250.00M	2.14B	460.00M	872.00M
Balance Sheet
Total Assets	29.34B	33.75B	34.27B	17.40B	16.02B
Cash, Cash Equivalents and Short-Term Investments	1.90B	2.72B	2.56B	2.88B	2.05B
Total Debt	5.66B	5.37B	4.83B	3.06B	3.10B
Total Liabilities	10.92B	11.05B	11.20B	6.56B	6.62B
Stockholders Equity	18.24B	22.51B	22.91B	10.74B	9.32B
Cash Flow
Free Cash Flow	624.00M	1.01B	710.00M	279.00M	994.00M
Operating Cash Flow	1.39B	1.78B	1.26B	923.00M	1.43B
Investing Cash Flow	392.00M	-252.00M	-726.00M	871.00M	208.00M
Financing Cash Flow	-2.58B	-1.33B	-820.00M	-598.00M	-984.00M

DSM-Firmenich AG Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 60.74
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:DSFIR, the sentiment is Negative. The current price of 60.74 is above the 20-day moving average (MA) of 59.03, below the 50-day MA of 61.93, and below the 200-day MA of 73.23, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 52.02 is Neutral, neither overbought nor oversold. The STOCH value of 81.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NL:DSFIR.

DSM-Firmenich AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AKZA	63 Neutral	€8.71B	4.23	14.61%	3.38%	-2.03%	-89.67%
MT	63 Neutral	€34.71B	10.68	6.11%	1.24%	-5.35%	―
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
DSFIR	52 Neutral	€14.55B	-2.82	―	3.61%	4.46%	―
AMG	49 Neutral	€1.15B	-55.26	6.84%	1.46%	9.94%	―
OCI	47 Neutral	€725.14M	2.88	―	229.25%	―	―
APAM	46 Neutral	€2.48B	283.16	-0.24%	5.41%	-2.24%	-102.76%